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Abstract 
Objective: To describe the sample size calculation, analysis and reporting of split-plot randomised 
controlled trials (RCT) in healthcare (trials that use two units of randomisation: one at a cluster-level 
and one at a level lower than the cluster).  
Study design and setting: We carried out a comprehensive search in the EMBASE database from 
1946 to 2016. Healthcare trials with a split-plot design in human subjects were included. Three 
authors screened and assessed the studies and data were extracted on methodology and reporting 
standards based upon CONSORT.  
Results: 18 split-plot studies were included, with authors using nine different designations to 
describe them. Units of randomisation were unclear in nine abstracts. Explicit rationale for choosing 
the design was not givenTen studies presented a sample size calculation accounting for clustering; 
the analyses were coherent with that. Flow of participant diagrams were presented but incomplete 
in 14 articles.  
Conclusion: Split-plot designs can be useful complex designs, but challenging to report. Researchers 
need to clearly describe the rationale, sample size calculation and participant flow. We provide a 
suggested CONSORT style participant flow diagram to aid reporting. There is need for more research 
regarding sample size calculation for split-plots. 
Word count: 193/200  
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1. Introduction 
Randomised controlled trials (RCT) usually allocate individual participants  to each of the 
interventions under evaluation (referred to here as a ‘standard RCT’) 
1
. The standard RCT may be 
replaced with a factorial RCT when researchers are interested in testing the effects of two or more 
interventions on the same outcome. In a full factorial RCT every participant is randomised to receive 
(or not) every intervention. 
2
 Factorial RCTs can be statistically efficient compared with standard 
RCTs, assuming no interaction effects between the interventions.
3
  
Some interventions are not suitable for evaluation using a standard RCT and there is a need to 
randomise groups of individuals (cluster randomised trial, C-RCT), for example: wards, hospitals, or 
communities. Cluster randomised trials are usually used either because it’s not feasible to randomise 
the individual or to avoid intervention contamination (the unintentional spill-over of intervention 
effects from one treatment group to another) 
4
. 
The factorial RCT can be adapted to involve randomising clusters of individuals. Factorial C-RCTs 
have been increasingly promoted due to their potential efficiency. 
2,5
 If the interventions target the 
same group of individuals (i.e. cluster) or must for ethical or administrative reasons be randomised 
at the cluster level, a factorial cluster RCT might have all interventions randomised at the same level. 
However, if the interventions target different levels (e.g. schools and teachers; hospitals and 
doctors; work sites and managers) a design which randomises one of the interventions at the cluster 
level and the other at the participant level could be useful. There are also practical issues that might 
dictate the need for two units of randomisation: for example, the costs of adding clusters might be 
superior to the costs of adding participants within clusters. 
6
 This type of design is called a split-plot 
(S-P) design. As an example, the IQuaD trial randomised dental practices to provide either routine or 
personalised oral hygiene advice to all of their dental patients. Each dental patient within a practice 
was also randomly allocated to receive either none, 12-monthly or 6-monthly scale and polishes.
7
  
Split-plot designs have been used in the healthcare literature and can be a useful design when 
evaluating two treatments at different levels, however to our knowledge there has been no 
systematic evaluation of the methodology used in the reporting and analysis of S-P designs in 
healthcare research. Doing so can identify potential limitations in the methodology of these studies, 
contributing for their improvement, as well as highlight the existence and purpose of this design. The 
aim of this study was to review the use of S-P designs conducted in healthcare with a special focus 
on relevant CONSORT items, 
4,8
 the sample size calculation and statistical methods used in the 
analysis.  
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2. Methods 
The study protocol is available from the authors. 
2.1. Data sources 
We searched studies published from January 1946 to March 2016 and listed on the EMBASE 
database. We did not screen abstracts that had already been screened and identified by an existing 
review of factorial C-RCTs that identified seven split-plot designs from 1946 to 2012.
5
 The search 
strategy was designed to identify factorial and cluster designs and RCTs, and was limited to English, 
Portuguese and Spanish language studies. The search strategy is shown in Appendix A.  
2.2. Eligibility criteria 
We included primary publications of RCTs conducted in human subjects. We excluded secondary 
analyses, economic evaluation, pilot studies and protocols. We defined an S-P as a design with two 
units of randomisation: one at the cluster-level and another within the cluster; if the second 
randomisation was within the intervention cluster only, we called this a partial S-P; when outcome 
collection was at a lower level than the randomisations we called this a multi-stratum S-P; we 
defined a nested split-plot as a split-plot nested within a larger trial. Appendix B includes diagrams 
of the different types of split-plot design. 
2.3. Study selection 
BG conducted the searches. We quality checked 20 randomly selected abstracts. Agreement 
between three researchers (BG, GM and CR) was classified as the need to assess full text or not. If 
agreement between reviewers was greater than 80%, BG would proceed with the retrieval of full 
texts.  BG assessed full texts for inclusion in the final review. GM assessed 10% of the same full-texts. 
More than 80% of agreement was needed to proceed. A third reviewer (CR) arbitrated on 
disagreement. The data were extracted by BG and included: author, journal, year of publication, 
title, goal of the study, design, primary outcomes, sample size calculation, cluster and participant-
level intervention, number of clusters and participants, rationale of the design, statistical analysis, 
report of diagram for flow of  participants, and units of randomisation identified in the abstract. To 
quality assure data entry, we randomly selected 10% of included studies for double data extraction. 
Where there was disagreement a consensus about the appropriate approaches was sought and 
reached through discussion and those approaches were applied to the remaining studies. If the 
disagreement rate was higher than 10%, we would consider all the studies.  
2.4. Guidance on the report of S-P designs 
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Using the cluster 
4
 and standard 
8
 CONSORT statements  we identified, through a consensus 
discussion between the authors, topics from the checklists that deserved special consideration when 
reporting an S-P design. We identified the following: title and abstract, introduction (rationale), 
sample size, statistical methods, results (participant flow). We provide comment and guidance on 
the report of these specific topics. 
2.5. Case study: IQuaD 
To introduce the S-P design in a more detailed way, we will describe IQuaD as a case study 
7
. IQuaD 
was a multi-level factorial cluster randomised trial, multi-centre with blinded outcome evaluation 
based in dental primary care in Scotland and North East of England. Clinicians recruited 1,860 adult 
patients. Dental practices were cluster randomised to provide routine oral hygiene advice or 
personalised. To test the effects of periodontal instrumentation (scale and polish, SP) each individual 
patient participant was randomised to one of three groups: no SP, 6-monthly SP (current practice) 
and 12-monthly SP. The primary objectives of IQuaD were to test personalised OHA versus routine 
OHA and no SP versus 6-monhtly SP. It was assumed there wouldn’t be a “substantive interaction 
between the SP interventions and the personalised OHA”. IQuaD had two primary outcomes: 
gingival inflammation / bleeding on probing at the gingival margin at 3 year follow-up and oral 
hygiene self-efficacy at 3 year follow-up.  
3. Results 
3.1. Literature search and study selection 
The agreement for retrieval of full-texts was 90%. After obtaining the full-texts, agreement on 
whether those were split-plot designs was 100%. 
From 8,245 abstracts found, 154 full texts were assessed and from those 136 were excluded (Figure 
2). The most common reasons for exclusion were cluster randomised trials with no factorial element 
(n=63) and cluster factorial designs with one randomisation unit (n=47).  
  
 
>> insert Figure 1 – PRISMA diagram<< 
3.2. Characteristics of included studies 
Eighteen studies were included in the review: eleven were traditional S-P designs, four were partial, 
two were multi-stratum and one was a nested S-P design.  
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The included studies were published between 2002 and 2016 (Table S1, Supplemental material). 
Researchers used nine different designations to describe the S-P design. Nine studies referred clearly 
two different randomisation units in the abstract. The remaining studies were unclear, using 
expressions such as “subtrial” 
9
, “embedded” 
10
 , “patient-level” and “community-level” intervention 
11,12
. Article titles had incomplete information about the design: four didn’t mention randomisation; 
four stated “cluster randomised”; no study mentioned the factorial design.  
At the cluster-level, the units of randomisation were using health related units (n=8), geographical 
clusters (n=4), health professionals (n=4), nursing homes (n=1) and schools (n=1). The number of 
clusters included varied from 6 to 91. At the participant-level, the majority of the studies used 
individuals as the unit of randomisation (n=11).  
Many interventions at the cluster-level were education related, for example: osteoporosis’ 
workshops, 
12
 school education interventions 
9
 and training in shoulder disorders. 
13
 At the 
participant-level, the types of interventions included tailored letters 
14
 or e-mails 
12
, timing of 
intervention 
15
 or physiotherapy sessions.
16
  Two studies evaluated a drug intervention at the 
participant level. 
17,18
  
Some studies did not state a reason for choosing the design (n=7), others stated that there was an 
interest in assessing the interaction between interventions (n=5) or to avoid contamination by using 
cluster randomisation (n=4).  No explicit justification is given by any of the trials to randomise two 
units, but one study hypothesized that interventions addressing multiple levels of a structure (such 
as individual, community, policy) might be more effective at changing behaviour than those focusing 
on a single level. 
12
  
Half of the studies included (n=9) had a primary aim related to implementation of guideline 
interventions (such as promoting colorectal cancer screening in primary care), followed by health 
(n=5) and public health interventions (n=2). 
3.3. Sample size calculation and analysis  
Twelve studies presented a sample size calculation (two as a post hoc power calculation) (Table 2). In 
all of them, except two, an intraclass correlation or inflation factor was used to account for the 
clustered nature of the data. From those, four studies were unclear about the comparison level used 
to calculate the sample size
10,15,19,20
, one study used a cluster level comparison only
21
, one study used 
a participant level comparison only
22
, two studies presented both comparison levels
9,23
 and two 
studies used a clinical meaningful difference to calculate their sample size
16,18
. Of the two studies 
that did not use an inflation factor, one used a participant level comparison
17
 and the other was 
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unclear about the comparison level
24
. No study based its sample size calculation on the interaction 
between the two interventions. All studies but one 
17
 ignored the interaction between the 
interventions in the sample size calculation. 
The analyses used in S-P designs were in general consistent with the sample size calculation. 
Hierarchical models and generalised estimating equations  were the most commonly used 
approaches to account for clustering. Five studies used separate models to analyse the cluster and 
individual components of the studies - three studies included the intervention at the cluster-level in 
a multilevel model and analysed the participant-level with a simpler model without adjustment for 
clustering. 
11,16,23,25
, the other studies used a cluster-level analysis. 
21,25
  
The interaction result was reported in most of the papers (9 out of the 14 eligible studies).
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1
 Partial split-plots do not have a factorial design and therefore cannot present an interaction result 
>>insert Table 2 – Sample size calculation, analysis and interaction considerations<< 
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3.4. Flow of participants’ diagram  
The majority of the trials had a flow of participants’ diagram (15/18) that focused on both the cluster 
and participant-level interventions (13/15) but all studies, except one, had incomplete information. 
The description of who or what was randomised and how many units were randomised were the 
most common information reported in the diagrams, whereas the number of clusters or participants 
lost to follow-up were the most commonly missed (Table 3).  
>> insert Table 3 Quality of information presented regarding the flow of participants<< 
 
 
3.5. CONSORT diagram suggestion 
We developed a diagram that incorporates the CONSORT suggestions for C-RCT 
4
 and individually 
RCTs. The diagram presents information about the number of clusters assessed and randomised, the 
average cluster size and a measure of variation, and then how many participants were assessed, 
randomised and analysed within the cluster interventions (Appendix C).  
4. Discussion 
This review is, to our knowledge, the first review about methodological issues and statistical analysis 
focused exclusively in S-P designs. We included eighteen studies and found different design 
variations. We identified key items of the CONSORT statement to focus on when using S-P designs 
and limitations in their design and report. Sample size calculations were one of the most challenging 
issues in the design of S-Ps: they were either omitted or based on the cluster randomisation element 
of the design, even though the evidence to do that is unclear. Finally, we provided a flow of 
participants’ diagram template to report S-P designs in a clear way.  
Variations of S-P designs had common features: the randomisation of two different entities, their 
sample size calculation and analysis, as well as their report. This suggests similar rationales for 
choosing the design, even though that was not made explicit by researchers. Logistic and design 
issues, such as the inability to randomise all the participants in the clusters (because, for example, 
participants were not willing to participate or didn’t comply with the eligibility criteria), were found 
across designs. Each type of S-P design presents different challenges: partial S-P designs do not have 
a factorial element and multi-stratum S-P designs have more than two levels of information to 
report (the randomisation units, as well as the outcome collection level).  
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Reporting of CONSORT items was suboptimal, particularly those that require special consideration in 
S-P designs. We recommend researchers using this design to: use a designation for the S-P trial that 
helps other researchers understand the design – for example “multi-level factorial cluster 
randomised trial”  when describing their studies; clearly present the randomisation units and the 
different interventions used in the abstract; and make their rationale explicit for choosing this 
design. 
Estimating the sample size and statistical power for a study is an essential part of its design with 
implications on its statistical precision 
6
. Calculating a sample size for S-P designs is challenging due 
to treatment at multiple levels (cluster and participant) and correlation at multiple levels (within-
cluster and within-participant). There is no closed formula for that purpose and statistical simulation 
may be the best technique 
6
 However, none of the studies included a simulation-based sample size 
calculation, which could be due to the technical knowledge needed to do so. Six studies presented 
no sample size calculation and this is a similar prevalence when compared with cluster RCTs 
26
. 
To calculate a sample size for an S-P design, the factorial and cluster randomised elements need to 
be considered using formulae available
27
 and an inflation factor should be used to account for the 
clustered nature of the data. However, there is need for more research regarding the estimation of 
sample sizes in S-P designs and space for improvement in terms of its current reporting. When using 
a sample size calculation in S-P designs, researchers based it on the cluster-level randomisation 
target treatment difference. This approach is reasonable if the target treatment difference is 
assumed to be the same or bigger for the participant-level intervention. Such an approach will lead 
to the participant trial component having more power than the C-RCT component of the study. 
However, this was not made explicit in most of the trials sample size rationale. The primary interest 
of the trial will also have implications for its sample size calculation: an S-P design can be chosen 
when the interest is to determine whether there is an interaction or not between interventions, but 
it could equally be chosen when it is clear there is no interaction between interventions. We 
recommend that the target difference for each intervention in the S-P design is presented, unless its 
sample size is based on  a clinical meaningful difference 
28
. If there is an interest in the interaction 
between interventions, that should be made explicit as well as the expected consequences for the 
sample size of the trial. Besides helping assessing researchers’ assumptions, it would reduce the risk 
of overvaluing a statistically significant result that is clinically meaningless.  
We considered the analysis used in the S-P designs reported here to be mostly adequate and 
coherent with the available sample size calculations. Since this design is challenging to implement 
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and report, this could reflect the fact that more experience researchers or methodologists are opting 
to use it.  
S-P designs should present results regarding interaction between interventions, when applicable, 
and make their a priori hypothesis explicit to facilitate assessment of whether a factorial design is an 
appropriate one. 
5,29
 One of the reasons to use a traditional S-P design is an interest in the 
interaction between two interventions (comparable to other types of factorial designs 
5
 
29
), but only 
one study accounted for that in its design.  
We recommend researchers using an S-P design to use a complete and understandable flow of 
participants’ diagram, such as the one we present in Appendix C. Flow of participants’ diagrams 
were particularly challenging to understand in the included studies, possibly due to the complexity 
of the design. The CONSORT diagram is a tool to aid the understanding of a trial, but there needs to 
be a trade-off between the amount of information provided and its clarity – there is no gain in 
presenting a lot of information in a diagram, if it is harder for the reader to follow.  
S-P designs were challenging to identify and assess: out of the 154 full texts assessed, 18 ended up in 
our review which reflects the variety of terms used to describe it and the lack of information about 
randomisation units in the abstract. Even after identifying a study as an S-P design, abstracting its 
elements was testing and had to be resolved by discussion between researchers. The difficulty 
identifying S-P designs leads to the unavoidable limitation of possibly overlooking studies. However 
our process was submitted to a quality check and an agreement was achieved between the three 
reviewers to ensure a high-level standard of the screening process.  
 
5. Conclusion 
S-P designs are potentially efficient and widely applicable designs that help answer complex, multi-
level research questions. In this review, we found several limitations in their report and design, 
including challenges for calculating their sample sizes. We recommend researchers using this design 
to comply with the CONSORT guidelines, giving special consideration to the key items of rationale, 
sample size, statistical methods and flow of participants’ diagram.  
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Sample size calculation - n  
Reported 12 
Not reported 6 
Type of sample size calculation - n  
Reported to use inflation factor  10 
Cluster level comparison presented  1 
Participant level comparison presented 1 
Both comparison levels presented 2 
Used clinical meaningful difference 2 
Comparison level unclear 4 
Did not report an inflation factor  2 
Participant level comparison presented 1 
Comparison level unclear 1 
Analysis – n . 
Hierarchical model 12 
Generalised estimating equations 4 
Aggregated analysis 2 
Interaction report – n . 
Yes 9 
No 3 
Unclear 2 
Not applicable
1 
4 
1
 Partial split-plots do not have a factorial design and therefore cannot present an interaction result 
Table 2 – Sample size calculation, analysis and interaction considerations 
 
CONSORT diagram items Number of articles included in which the information 
indicated is present in the diagram (N=18) 
Diagram presented 15 
Cluster-randomisation level  
Number of clusters assessed for 
eligibility  
11 
Number of clusters randomised 13 
Average cluster size or equivalent 
(mean/median) 
3 
Range of cluster size or equivalent 
(variance, standard deviation) 
3 
Number of clusters lost to follow-up 3 
Number of cluster analysed 3 
Participant-randomisation level  
Number of participants assessed for 
eligibility  
8 
Number of participants randomised 13 
Number of  participants lost to follow-up 12 
Number of participants analysed 14 
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Table 3 Quality of information presented regarding the flow of participants 
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Figure 1 – PRISMA diagram 
 
8,245 abstracts found
154 full texts assessed
18 studies included
8,091 records excluded
136 full texts excluded due 
to:  
63 cluster randomised only, 
47 cluster factorial with 1 unit 
of randomisation,  
9 factorial, 8 not a primary 
report, 1 non-randomised 
trial, 4 parallel arm trial, 4 
didn’t randomise one of the 
units 
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What is new? 
Split-plot designs are used mainly for education and implementation of guidelines’ research and 
there are several variations of the design: we classified these as traditional, partial, multi-stratum 
and nested split-plot designs. 
We identified key items of the CONSORT statement to focus on when using split-plot designs, such 
as the rationale, sample size, statistical methods and flow of participants’ diagram and limitations in 
their design and report. We provide guidance on how to report these key items, as well as suggested 
a flow of participants’ diagram to help visualise the complex structure of the design and its flow of 
participants’.  
Sample size calculations for the split-plot design are challenging due to its complex structure and 
need to take into account different levels of correlation. There is need for more research on how to 
calculate sample sizes for split-plot designs, but included trials could improve on the report and 
clarity of their calculations. Potential interaction between interventions is one of the reasons to use 
this design, however all but one trial ignored interaction at the design stage. 
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